| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.3 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.4 |